Discovery of 4-Quinazolinone-bearing Phenylalanine Derivatives as HIV-1 Capsid Inhibitors with Potent and Insensitivity Towards Clinically Relevant Resistant Mutations
Zhang, X., Walsham, L., Zhan, P., Goldstone, D.C.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Spacer peptide 1 | A [auth B], B [auth C], C [auth A] | 229 | Human immunodeficiency virus 1 | Mutation(s): 4  Gene Names: gag | ![]() |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P12493 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| A1ADQ (Subject of Investigation/LOI) Download:Ideal Coordinates CCD File | D [auth B], F [auth C], I [auth A] | N-[(1S)-1-[(3P,7M)-3-{4-chloro-3-[(ethanesulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-7-(3-fluoro-4-formylphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[3-(trifluoromethyl)-5,6-dihydrocyclopenta[c]pyrazol-1(4H)-yl]acetamide C43 H32 Cl F9 N8 O5 S AIQQZDCVPIRQSU-UHFFFAOYSA-N | |||
| IOD Download:Ideal Coordinates CCD File | E [auth B], G [auth C], H [auth C], J [auth A] | IODIDE ION I XMBWDFGMSWQBCA-UHFFFAOYSA-M | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 160.268 | α = 90 |
| b = 160.268 | β = 90 |
| c = 57.235 | γ = 120 |
| Software Name | Purpose |
|---|---|
| REFMAC | refinement |
| XDS | data reduction |
| Aimless | data scaling |
| PHASER | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| Not funded | -- |